New biomarkers may spot kidney injury faster after surgery

NCT ID NCT07088874

Recruiting now Knowledge-focused Sponsor: Peking University First Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether certain substances in urine and blood can predict acute kidney injury and chronic kidney disease after radical nephrectomy (complete kidney removal). Researchers will monitor 60 adults undergoing this surgery, collecting samples at several time points. The goal is to find markers that are more sensitive and faster than current standard tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better, faster ways to detect kidney damage after surgery, helping doctors intervene earlier.
What could go wrong: This is a small, early-stage exploratory study with only 60 participants. The biomarkers may not prove reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY BIOMARKER NEPHRECTOMY

Contacts and locations

Locations

Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital
RECRUITING

Beijing, Beijing Municipality, 100034, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.